[373] in peace2
Seminar: Business Side of Biotech (fwd)
daemon@ATHENA.MIT.EDU (Aimee L Smith)
Tue Sep 19 17:14:58 2000
Message-Id: <200009192114.RAA01613@emat1.mit.edu>
To: peace-list@MIT.EDU, jaking@MIT.EDU
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Date: Tue, 19 Sep 2000 17:14:49 -0400
From: Aimee L Smith <alsmith@MIT.EDU>
In the wake of what we learned at Bio-dev, we might have some
questions for this genomics company rep! Perhaps Prof. King
could come up with a few "bullets" on this company/issue?
In unity,
Aimee
------- Forwarded Message
Date: Tue, 19 Sep 2000 16:36:45 -0400
To: mseg@mit.edu, sums@mit.edu
From: "Kathleen R. Farrell" <krf@MIT.EDU>
Subject: Seminar: Business Side of Biotech
Materials Science and Engineering Students,
Please note this upcoming seminar announcement from the MIT Science and
Engineering Business Club:
MIT-Science and Engineering Business Club with HST
- -----------------------------------------------------------------------------
--
Come hear about the future of biotech from Dr. Noubar Afeyan. We're
fortunate to have Dr. Afeyan speak. He was the initiator of Celera
Genomics, the company that sequenced the human genome with the Human Genome
Project.
Dr. Afeyan is now the President and CEO of Newcogen, a biotech and
high-tech incubator. He is also a Senior Lecturer at Sloan.
- -----------------------------------------------------------------------------
---
- -
Entrepreneurship in the Life Sciences Field:
Opportunities and Experiences
DR. NOUBAR AFEYAN
Thursday, Sept. 21
7:00 p.m.
6-120
pizza will be served!
http://web.mit.edu/sbc
John Lo
President and Co-Founder
MIT-Science and Engineering Business Club
johnlo@MIT.EDU
------- End of Forwarded Message
